Yezan Haddadin joined GMS Holdings in 2017 to build and lead the company’s newly created investment management platform, GMS Capital Partners LLC. Yezan has over 20 years of investment banking and private equity experience. Throughout his career, he has developed extensive experience across a range of industries and advised on over USD 100 billion in M&A transactions in North America, Latin America, Europe, the Middle East and Africa.

Prior to joining GMS Holdings, Yezan was the Chief Executive Officer and Board Member of a regional investment bank based in Amman and Dubai (2014-2017); Advisor at Ripplewood Holdings LLC, a New York-based private equity firm (2013-2014); Managing Director at Perella Weinberg Partners in New York (2007-2013) and an Executive Director in JPMorgan’s M&A Group in New York (2000-2007).

Yezan is currently a member of the Board of Directors at Outlook Therapeutics, a NASDAQ-listed, New Jersey-based late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications.  Yezan is also a member of the Board of Directors of Jordan Ahli Bank.  Yezan is a Fellow of the sixth class of the Middle East Leadership Initiative and a member of the Aspen Global Leadership Network. Previously, he was a member of the Board of Directors at Sixth of October Investment Company (SODIC), a publicly listed Egyptian real estate development company and a Board Member of The Near East Foundation, a New York- based private nonprofit development agency with projects in Africa and the Middle East.

Yezan holds a Juris Doctor from Northwestern University School of Law (USA) and a Bachelor of Science from Georgetown’s School of Foreign Service (USA). He is admitted to the New York State Bar and is an FAA licensed pilot.